Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AllVac
São Paulo, São Paulo, Brazilallvac.com.br ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
AllVac is a Brazilian biotechnology company specializing in the development and production of vaccines and biological products. The company operates a modern manufacturing facility focused on high-quality immunobiologicals for both human and veterinary health. AllVac gained significant prominence through its involvement in the production and distribution of COVID-19 vaccines in the South American market. Beyond manufacturing, the company provides contract manufacturing services and technical consultancy for biotechnology projects. Its business model integrates research, development, and large-scale production to address public health challenges in the region.
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccineBiologic
- Industry
- Biotech
02
Partnerships
Butantan InstituteFiocruz
Beyond the preview
Go deeper on AllVac.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AllVac.